A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes.
Saved in:
| Title: | A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes. |
|---|---|
| Authors: | Wang, Ju1 (AUTHOR) ju.wang@pfizer.com, Casimiro-Garcia, Agustin2 (AUTHOR), Johnson, Bryce G.1 (AUTHOR), Duffen, Jennifer1 (AUTHOR), Cain, Michael1,3 (AUTHOR), Savary, Leigh1,4 (AUTHOR), Wang, Stephen5,6 (AUTHOR), Nambiar, Prashant7,8 (AUTHOR), Lech, Matthew1 (AUTHOR), Zhao, Shanrong9,10 (AUTHOR), Xi, Li11 (AUTHOR), Zhan, Yutian7 (AUTHOR), Olson, Jennifer12 (AUTHOR), Stejskal, James A.12,13 (AUTHOR), Lin, Hank7,14 (AUTHOR), Zhang, Baohong9,15 (AUTHOR), Martinez, Robert V.1,16 (AUTHOR), Masek-Hammerman, Katherine7 (AUTHOR), Schlerman, Franklin J.1 (AUTHOR), Dower, Ken1 (AUTHOR) ken.dower@pfizer.com |
| Source: | Scientific Reports. 11/22/2023, Vol. 13 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
